Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant

Clinical trial NCT04044560 · TERMINATED

Trial details

NCT number: NCT04044560
Sponsor: University of British Columbia
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Adult Acute Lymphoblastic Leukemia Stem Cell Leukemia Minimal Residual Disease

Start date: 2020-09-08
Primary completion: 2022-02-02
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.